GlassScriptPhysician profile
John Burleson
NPI 1255779948
$184,211.17
in general payments reported to CMS, 2019-2025
47 companies · $37K in 2025
The $37K reported for 2025 was more than what 84% of Orthopaedic Surgery of The Spine providers received nationally (typical 2025 total: $2,116).
See the full distribution for Orthopaedic Surgery of the Spine
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $12K · 2021: $29K · 2022: $37K · 2023: $27K · 2024: $32K · 2025: $37K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $72K · Travel and Lodging: $13K · Food and Beverage: $8,028 · Royalty Or License: $2,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $72,476.99 |
| Travel and Lodging | $12,838.59 |
| Food and Beverage | $8,027.71 |
| Royalty Or License | $2,400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ulrich Medical USA, INC. | $56,061.09 | 2021-2025 | |
| Degen Medical, INC. | $38,172.74 | 2020-2025 | Xr |
| Silony Medical Corp. | $20,662.78 | 2021-2023 | Verticale Winx |
| Alphatec Spine, INC | $14,763.53 | 2021-2023 | Other - Miscellaneous, Battalion Tlif - PC |
| Ctl Medical Corporation | $8,229.46 | 2020-2021 | |
| Restor3d, INC. | $8,221.29 | 2023 | |
| Nuvasive, INC. | $8,000.00 | 2019 | |
| Theragen, INC. | $6,426.09 | 2022-2024 | Actastim-S |
| Cerapedics INC. | $3,614.01 | 2021-2025 | I-Factor Peptide Enhanced Bone Graft |
| Intrinsic Therapeutics | $3,470.59 | 2025 | Barricaid Acd (Annular Closure Device) |
| Medacta USA, INC. | $3,156.21 | 2020-2025 | Myspine |
| Kalitec Direct LLC | $2,364.35 | 2020-2022 | |
| Si-Bone, INC. | $2,033.65 | 2020-2024 | |
| Medical Device Business Services, INC. | $1,429.96 | 2019 | |
| Integrity Implants INC. Dba Accelus | $1,312.42 | 2023-2024 |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Centinel Spine, LLC | $1,223.30 | 2021-2022 | |
| Spineart USA INC | $1,126.43 | 2019 | |
| Orthofix Medical, INC. | $508.06 | 2019-2025 | Spinal-Stim, Cervical-Stim, Physio-Stim |
| Medtronic USA, INC. | $471.75 | 2019-2020 | |
| Amgen INC. | $449.60 | 2023-2025 | Evenity, Prolia |
| Stryker Corporation | $360.04 | 2019-2023 | Spinejack |
| Providence Medical Technology, INC. | $276.94 | 2020-2025 | |
| Implanet America, INC. | $214.24 | 2024 | |
| Augmedics INC. | $199.78 | 2020-2025 | Xvision |
| 4web, INC. | $176.41 | 2020-2021 | |
| Zimvie INC. | $174.20 | 2023 | |
| Spineology INC. | $166.59 | 2022-2023 | Optimesh Expandable Interbody Fusion System |
| Acuity Surgical Devices, LLC | $142.11 | 2020 | |
| Globus Medical, INC. | $95.44 | 2021 | |
| Nexxt Spine LLC | $90.76 | 2024 | Connexx Systems, Matrixx Sa System, Si System |
| Biogennix, LLC | $87.08 | 2021 | |
| Depuy Synthes Sales INC. | $68.20 | 2019-2021 | |
| Arteriocyte Medical Systems, INC. | $61.51 | 2020-2022 | |
| Seaspine Orthopedics Corporation | $48.94 | 2020 | |
| Djo, LLC | $48.91 | 2021-2023 | Cmf |
| Spinal Elements, INC. | $33.06 | 2020 | |
| Life Spine, INC. | $32.26 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $31.74 | 2022 | |
| Medtronic, INC. | $28.70 | 2021 | |
| Smith+Nephew, INC. | $26.28 | 2021 | |
| Aesculap Implant Systems, LLC | $25.33 | 2020 | |
| Radius Health, INC. | $25.01 | 2021 | |
| Innovation Technologies INC | $24.31 | 2025 | Irrisept |
| Relievant Medsystems, INC. | $22.42 | 2022 | |
| Kowa Pharmaceuticals America, INC. | $20.36 | 2023 | Seglentis |
| Avanos Medical | $19.21 | 2021 | |
| Kci USA, INC. | $14.03 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$3,051.06 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Burleson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.